Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fiocruz vaccine effectiveness against SARS-CoV-2 variants in Botucatu
RBR-8yrrf9sTerminated
- Sponsor
- Universidade Estadual Paulista
- Start
- May 2021
- Countries
- 1
01
Overview
Open-label, single-arm trial in coronavirus disease 2019 (COVID-19), sponsored by Universidade Estadual Paulista. Primary endpoint: SARS-CoV-2 infection detected by RT-PCR. Started May 2021; status: terminated.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-8yrrf9s.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8yrrf9s.